Moderate to Severe Alzheimer
1 clinical trials · Condition
◉ Watch Moderate to Severe Alzheimer
| Record | Firm | Date |
|---|---|---|
| A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease (NCT00954590) | Medivation, Inc. | 2009-10-01 |
Track Moderate to Severe Alzheimer automatically
Every clearance here is in the API, with alerts when new ones post.